- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Biocon Biologics appoints Deepali Naair as Global Head - Brand & Corporate Communications

Bengaluru: Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited, has announced the appointment of Deepali Naair as Global Head - Brand & Corporate Communications, effective immediately.
Deepali will lead the global brand and corporate communications function, responsible for defining and executing an integrated strategy that spans brand positioning, digital presence, regulatory and statutory communications, financial and corporate reporting, media relations, and employer branding.
Deepali will join the Executive Leadership Team (ELT) and report directly to Shreehas Tambe, CEO & Managing Director, Biocon Biologics Limited. She will be based at Biocon House, Bengaluru.
With over three decades of experience across India, ASEAN, and Australia, Deepali brings deep expertise in brand building, marketing, and corporate reputation. In her most recent role as Group Chief Marketing Officer at CKA Birla Group, she was instrumental in shaping the Group’s corporate identity, launching new brands, and driving strategic transformations. She also worked at IBM, IIFL Wealth Finance Ltd, IIFL Investment Managers, Mahindra Holidays & Resorts India Limited, L&T General Insurance Company Limited, HSBC Asset Management India Private Limited, EMM Group, Marico, FCB Ulka Advertising, BPL Mobile Communications Ltd, and Tata Motors.
Seema Ahuja, who was the Head of Communications for Emerging Markets and Corporate Brand, will post her retirement from Biocon Biologics and move into a non-business facing role in Biocon Chairperson’s office to work on special projects.
Shreehas Tambe, CEO & Managing Director, Biocon Biologics Limited, said, “Branding and communications play a pivotal role in shaping stakeholder perception, building trust, and translating corporate intent into meaningful narratives. As Biocon Biologics accelerates its journey to become a leading global biosimilars company, I am delighted to welcome Deepali and look forward to her leadership and expertise in shaping our global brand and communications strategy."
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751